Associations of insulin resistance surrogate with resistant hypertension and the severity of hypertension in the chronic kidney disease population
Authors:
Open Access
- 20 August 2025
- journal article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 43 (11) , 1841-1851
Abstract
Background: Extensive research has explored the relationship between the triglyceride–glucose (TyG) index and hypertension, yet the associations of the TyG index with resistant hypertension and the severity of hypertension in the chronic kidney disease (CKD) population remain unclear. Methods: We analyzed data from 3944 CKD participants in the NHANES survey (1999–2020). Binary and ordered logistic regression analyses assessed the TyG index's impact on hypertension categories (uncontrolled, resistant, and refractory hypertension) and severity. Results: Higher TyG index quartiles were significantly associated with higher odds of hypertension categories after adjustments for covariates. Specifically, the odds ratios (ORs) for the highest quartile were 1.68 (1.27–2.22) for uncontrolled hypertension, 2.24 (1.41–3.58) for resistant hypertension, and 2.17 (1.18–3.99) for refractory hypertension compared to the lowest quartile. The continuous TyG index showed similar trends, with ORs of 1.28 (1.10–1.49), 1.54 (1.23–1.94), and 1.40 (0.97–2.01), respectively. Higher TyG index levels were also linked to greater hypertension severity. The ORs (Q2, 3, 4 vs. Q1) were 1.29 (1.01–1.65), 1.37 (1.10–1.72), and 1.80 (1.40–2.32), respectively. Each one-unit increase in the TyG index raised the OR for hypertension severity to 1.34 (1.17–1.53). Conclusion: This study demonstrated that an elevated TyG index is significantly associated with higher odds of uncontrolled, resistant, and refractory hypertension, as well as greater severity of hypertension. The findings underscored the utility of the TyG index as a valuable biomarker for evaluating resistant hypertension risk and hypertension severity among patients with CKD in community settings.Keywords
This publication has 46 references indexed in Scilit:
- KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular DiseasesKidney International, 2021
- Insulin resistance, cardiovascular stiffening and cardiovascular diseaseMetabolism, 2021
- The triglycerides and glucose index is associated with cardiovascular risk factors in metabolically obese normal-weight subjectsJournal of Endocrinological Investigation, 2020
- Use of Directly Observed Therapy to Assess Treatment Adherence in Patients With Apparent Treatment-Resistant HypertensionJAMA Internal Medicine, 2019
- The double challenge of resistant hypertension and chronic kidney diseaseThe Lancet, 2015
- Prevalence and Prognostic Role of Resistant Hypertension in Chronic Kidney Disease PatientsJACC, 2013
- The association between body mass index and incident hypertension in rural women in ChinaEuropean Journal of Clinical Nutrition, 2010
- Vascular stiffening and arterial complianceImplications for systolic blood pressureAmerican Journal of Hypertension, 2004
- Relationship between insulin sensitivity, hyperinsulinemia, and insulin-mediated sympathetic activation in normotensive and hypertensive subjectsAmerican Journal of Hypertension, 1996
- The effect of insulin on renal sodium metabolismDiabetologia, 1981